Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice
CONCLUSION: Antagonism of m3 alleviated type 2 inflammation in the nasal mucosa of AR mice.PMID:36343939 | DOI:10.1177/19458924221137977 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - November 7, 2022 Category: ENT & OMF Authors: Yu Chen Aijie Huang Guolin Tan Honghui Liu Source Type: research

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice
CONCLUSION: Antagonism of m3 alleviated type 2 inflammation in the nasal mucosa of AR mice.PMID:36343939 | DOI:10.1177/19458924221137977 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - November 7, 2022 Category: ENT & OMF Authors: Yu Chen Aijie Huang Guolin Tan Honghui Liu Source Type: research

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice
CONCLUSION: Antagonism of m3 alleviated type 2 inflammation in the nasal mucosa of AR mice.PMID:36343939 | DOI:10.1177/19458924221137977 (Source: American Journal of Rhinology and Allergy)
Source: American Journal of Rhinology and Allergy - November 7, 2022 Category: ENT & OMF Authors: Yu Chen Aijie Huang Guolin Tan Honghui Liu Source Type: research

Nhlbi asthma networks: improving patient care, moving toward personalized medicine
Trans Am Clin Climatol Assoc. 2022;132:44-60.ABSTRACTThe first NHLBI Clinical Trials Research Network was the Asthma Clinical Research Network (ACRN 1), which was born in 1993 to perform multiple controlled clinical trials for asthma: "… dispassionately examine new & existing therapies for asthma" and "… rapidly communicate findings to medical community," and therefore, to perform clinical trials drug companies could not or would not do. Among the many areas studied by the ACRN and its successor networks, through 2019, was how to effectively and safely use long-acting beta-agonists and to find novel alternatives fo...
Source: Transactions of the American Clinical and Climatological Association - October 5, 2022 Category: General Medicine Authors: Stephen P Peters Source Type: research